OC
ADAP

Oppenheimer & Co’s Adaptimmune Therapeutics ADAP Stock Holding History

Oppenheimer & Co’s Portfolio ADAP Stock Details ADAP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
2024
Q4 		$17.3K Sell
2024
Q3 		$34.5K Sell
2024
Q2 		$38.3K Sell
2024
Q1 		$69.3K Sell
2023
Q4 		$39.7K Sell
2023
Q3 		$53.2K Hold
2023
Q2 		$63.1K Buy
2020
Q4 		– Sell
2020
Q3 		$294K Buy